|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Neurocrine Biosciences, Inc.
| | | Phone: | (858) 617-7600 | Fax: | (858) 617-7601 | Year Established: | 1992 | Ticker: | NBIX | Exchange: | NASDAQ | Main Contact: | Kevin C. Gorman, Ph.D., CEO | | Other Contacts: | Haig Bozigian, Ph.D, Chief Development Officer Darin Lippoldt, Chief Legal Officer Malcolm Lloyd-Smith, Chief Regulatory Officer David-Alexandre "DA" Gros M.D., President & COO Eiry W. Roberts, M.D., CMO Kyle Gano, Ph.D, Chief Business Development Officer Dimitri E. Grigoriadis, Ph.D., Chief Research Officer Matt Abernethy, CFO
| | Company Description | Neurocrine Biosciences is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. | |
|
|
|
|
|